Cargando…
Combination of stromal vascular fraction and Ad-COMP-Ang1 gene therapy improves long-term therapeutic efficacy for diabetes-induced erectile dysfunction
Men with diabetic erectile dysfunction (ED) respond poorly to the currently available oral phosphodiesterase-5 inhibitors. Therefore, functional therapies for diabetic ED are needed. Stromal vascular fraction (SVF) and the adenovirus-mediated cartilage oligomeric matrix angiopoietin-1 (Ad-COMP-Ang1)...
Autores principales: | Yin, Guo-Nan, Wang, Lin, Lin, Xiang-Nan, Shi, Lei, Gao, Zhen-Lin, Han, Feng-Chan, Li, Ping, Jin, Yin-Chuan, Suh, Jun-Kyu, Ryu, Ji-Kan, Wang, Xiong, Jin, Hai-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116680/ https://www.ncbi.nlm.nih.gov/pubmed/29667617 http://dx.doi.org/10.4103/aja.aja_16_18 |
Ejemplares similares
-
AB171. Targeting Ninjurin-1 for future therapy of erectile dysfunction
por: Yin, Guo Nan, et al.
Publicado: (2014) -
Designed angiopoietin-1 variant, COMP-angiopoietin-1, rescues erectile function through healthy cavernous angiogenesis in a hypercholesterolemic mouse
por: Ryu, Ji-Kan, et al.
Publicado: (2015) -
AB035. Vasohibin-1 as a potential therapeutic target for erectile dysfunction
por: Song, Kang-Moon, et al.
Publicado: (2018) -
Differential Expression of Nerve Injury-Induced Protein 1 (Ninjurin 1) in In Vivo and In Vitro Models for Diabetic Erectile Dysfunction
por: Kim, Do Kyung, et al.
Publicado: (2012) -
AB007. Protein therapy to regenerate erectile tissue for future management of erectile dysfunction
por: Ryu, Ji-Kan, et al.
Publicado: (2018)